Ancora.ai vs Massive Bio
Ancora.ai
Ancora.ai is a patient-first, digital clinical trial navigation tool connecting cancer patients to clinical trials
9 employees · est. 2017 · Zurich, Switzerland
Massive Bio
AI-driven system connecting cancer patients to clinical trials in real time. Industrializing the oncology action layer
103 employees · est. 2019 · Istanbul, Turkey
Ancora.ai is the older company (2017 vs 2019); Massive Bio is the larger of the two.
Side-by-Side Comparison
| Metric | Ancora.ai | Massive Bio |
|---|---|---|
| Founded | ||
| Founded | 2017 older | 2019 |
| Headquarters | ||
| Headquarters | Zurich, Switzerland | Istanbul, Turkey |
| Employees | ||
| Employees | 9 | 103 larger |
| Industry | ||
| Industry | AI, Big Data, Health Care | AI, Big Data, Biotechnology |
| Funding Stage | ||
| Funding Stage | Grant | Series B |
| Total Funding | ||
| Total Funding | $465.00K | $28.10M |
| Funding Rounds | ||
| Funding Rounds | 6 | 7 |
| Services | ||
| Services | Not tracked yet | AI-driven clinical trial matching, Cancer patient support, Tailored medical reports, Financial assistance exploration, Insurance coverage review |
| Target Customers | ||
| Target Customers | Not tracked yet | Cancer patients, Physicians, Healthcare providers, Pharmaceutical companies, Clinical researchers |
| Taxonomy | ||
| Taxonomy | AI-drivenDigital Clinical TrialsPrecision MedicinePatient CentricityHealth EquityOncology +6 | AI-driven Oncology SolutionsClinical Trial MatchingOncology Trial EnrollmentReal-world EvidencePrecision OncologyNeurosymbolic Systems +9 |
| Website | ||
| Website | ancora.ai | massivebio.com |
About Ancora.ai
Ancora.ai is a Switzerland-based startup with a vision to revolutionize cancer patient care by providing access to clinical research through their patient-first, digital clinical trials hub. Their precision medicine trial matching technology personalizes trial results for cancer patients in minutes,...
About Massive Bio
Massive Bio, founded in 2014, is revolutionizing the oncology sector with its AI-driven system that connects cancer patients to clinical trials in real-time, thereby industrializing the oncology action layer. Operating in 17 countries across North America, Europe, and LATAM, this Turkey-headquartere...
Also comparing in this category
Comparing more than these two?
Get Ancora.ai, Massive Bio and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does Ancora.ai compare?
A PDF of Ancora.ai and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Frequently Asked Questions
Compare Ancora.ai with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Ancora.ai on 11 Sep 2024, and Massive Bio on 2 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
